This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Gastrointestinal cancer, also known as gastrointestinal tract cancer, is cancer that starts in the digestive system. The digestive system includes the esophagus, stomach, small intestine, large intestine, rectum, and anus. Gastrointestinal cancer includes cancers of the esophagus, stomach, small intestine, colon, rectum, anal canal, liver, gallbladder, and biliary tract. Gastrointestinal cancer is the second leading cause of cancer-related deaths in the United States. Common risk factors for gastrointestinal cancer include age, smoking, diet, and family history. Other risk factors may include chronic inflammation or infection, alcohol use, and certain inherited genetic syndromes. Early symptoms of gastrointestinal cancer vary depending on the type and location of the tumor. Common symptoms may include abdominal pain, nausea, vomiting, weight loss, blood in the stool, and changes in bowel habits. If you experience any of these symptoms, it is important to speak with your doctor. Diagnosis of gastrointestinal cancer usually involves imaging tests such as a CT scan, MRI, or endoscopy. If a cancer is confirmed, other tests may be used to determine the stage of the cancer.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States